Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 202

    1.

    A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin.

    Gangji AS, Cukierman T, Gerstein HC, Goldsmith CH, Clase CM.

    Diabetes Care. 2007 Feb;30(2):389-94.PMID: 17259518 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes.

    Moretti ME, Rezvani M, Koren G.

    Ann Pharmacother. 2008 Apr;42(4):483-90. Epub 2008 Mar 18.PMID: 18349305 [PubMed - indexed for MEDLINE]Related articles

    4.

    Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.

    Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL.

    Ann Intern Med. 2007 Sep 18;147(6):386-99. Epub 2007 Jul 16. Review. Erratum in: Ann Intern Med. 2007 Dec 18;147(12):887. PMID: 17638715 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies.

    Rao AD, Kuhadiya N, Reynolds K, Fonseca VA.

    Diabetes Care. 2008 Aug;31(8):1672-8. Epub 2008 May 5.PMID: 18458139 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Individual sulfonylureas and serious hypoglycemia in older people.

    Shorr RI, Ray WA, Daugherty JR, Griffin MR.

    J Am Geriatr Soc. 1996 Jul;44(7):751-5.PMID: 8675920 [PubMed - indexed for MEDLINE]Related articles

    7.

    Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.

    Dahabreh IJ, Economopoulos K.

    Clin Trials. 2008;5(2):116-20. Erratum in: Clin Trials. 2008;5(5):559. Economopoulos, K [added]. PMID: 18375649 [PubMed - indexed for MEDLINE]Related articles

    8.

    Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.

    Shorr RI, Ray WA, Daugherty JR, Griffin MR.

    Arch Intern Med. 1997 Aug 11-25;157(15):1681-6.PMID: 9250229 [PubMed - indexed for MEDLINE]Related articles

    10.

    Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.

    Qayyum R, Bolen S, Maruthur N, Feldman L, Wilson LM, Marinopoulos SS, Ranasinghe P, Amer M, Bass EB.

    Ann Intern Med. 2008 Oct 21;149(8):549-59. Epub 2008 Sep 15. Review.PMID: 18794553 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

    Singh S, Loke YK, Furberg CD.

    JAMA. 2007 Sep 12;298(10):1189-95.PMID: 17848653 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.

    Amori RE, Lau J, Pittas AG.

    JAMA. 2007 Jul 11;298(2):194-206. Review.PMID: 17622601 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Rates of hypoglycemia in users of sulfonylureas.

    van Staa T, Abenhaim L, Monette J.

    J Clin Epidemiol. 1997 Jun;50(6):735-41.PMID: 9250272 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hypoglycemia associated hospitalizations in a population with a high prevalence of non-insulin-dependent diabetes mellitus.

    Sugarman JR.

    Diabetes Res Clin Pract. 1991 Nov;14(2):139-47.PMID: 1756685 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia.

    Ramos GA, Jacobson GF, Kirby RS, Ching JY, Field DR.

    J Perinatol. 2007 May;27(5):262-7. Epub 2007 Mar 15.PMID: 17363911 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.

    Dailey G, Strange P.

    Am J Manag Care. 2008 Jan;14(1):25-30.PMID: 18197742 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies.

    Duckworth W, Davis SN.

    J Diabetes Complications. 2007 May-Jun;21(3):196-204. Review.PMID: 17493554 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data